These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33458836)

  • 1. Neuroprotective mechanisms of mangiferin in neurodegenerative diseases.
    Liu T; Song Y; Hu A
    Drug Dev Res; 2021 Jun; 82(4):494-502. PubMed ID: 33458836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of mangiferin in the treatment of various neuropsychiatric and neurodegenerative disorders.
    Walia V; Chaudhary SK; Kumar Sethiya N
    Neurochem Int; 2021 Feb; 143():104939. PubMed ID: 33346032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome analysis reveals the anti-Parkinson's activity of Mangiferin in zebrafish.
    Qin F; Zhang M; Wang P; Dai Z; Li X; Li D; Jing L; Qi C; Fan H; Qin M; Li Y; Huang L; Wang T
    Biomed Pharmacother; 2024 Oct; 179():117387. PubMed ID: 39245002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer's and Parkinson's disease models.
    Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y
    Pharmacol Res; 2019 Aug; 146():104336. PubMed ID: 31271846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mangiferin inhibited neuroinflammation through regulating microglial polarization and suppressing NF-κB, NLRP3 pathway.
    Lei LY; Wang RC; Pan YL; Yue ZG; Zhou R; Xie P; Tang ZS
    Chin J Nat Med; 2021 Feb; 19(2):112-119. PubMed ID: 33641782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mangiferin Potentiates Neuroprotection by Isoflurane in Neonatal Hypoxic Brain Injury by Reducing Oxidative Stress and Activation of Phosphatidylinositol-3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Signaling.
    Xi JS; Wang YF; Long XX; Ma Y
    Med Sci Monit; 2018 Oct; 24():7459-7468. PubMed ID: 30338764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Potential of Genipin in Central Neurodegenerative Diseases.
    Li Y; Li L; Hölscher C
    CNS Drugs; 2016 Oct; 30(10):889-97. PubMed ID: 27395402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mangiferin ameliorates intracerebroventricular-quinolinic acid-induced cognitive deficits, oxidative stress, and neuroinflammation in Wistar rats.
    Arora MK; Kisku A; Jangra A
    Indian J Pharmacol; 2020; 52(4):296-305. PubMed ID: 33078731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mangiferin ameliorates 6-hydroxydopamine-induced cytotoxicity and oxidative stress in ketamine model of schizophrenia.
    Rao VS; Carvalho AC; Trevisan MT; Andrade GM; Nobre-Júnior HV; Moraes MO; Magalhães HI; Morais TC; Santos FA
    Pharmacol Rep; 2012; 64(4):848-56. PubMed ID: 23087136
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Piwowar A; Rembiałkowska N; Rorbach-Dolata A; Garbiec A; Ślusarczyk S; Dobosz A; Długosz A; Marchewka Z; Matkowski A; Saczko J
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases.
    Subedi L; Gaire BP
    Pharmacol Res; 2021 Jul; 169():105661. PubMed ID: 33971269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson's disease mice.
    Kavitha M; Nataraj J; Essa MM; Memon MA; Manivasagam T
    Chem Biol Interact; 2013 Nov; 206(2):239-47. PubMed ID: 24095822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration.
    Chakrabarti M; Haque A; Banik NL; Nagarkatti P; Nagarkatti M; Ray SK
    Brain Res Bull; 2014 Oct; 109():22-31. PubMed ID: 25245209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits of hesperidin in central nervous system disorders, based on the neuroprotective effect.
    Li X; Huang W; Tan R; Xu C; Chen X; Li S; Liu Y; Qiu H; Cao H; Cheng Q
    Biomed Pharmacother; 2023 Mar; 159():114222. PubMed ID: 36628819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tongluojiunao, a traditional Chinese medication with neuroprotective ability: A review of the cellular, molecular and physiological mediators of TLJN's effectiveness.
    Bibak B; Teymouri M; Mohammadi A; Haghbin A; Pan Y; Kasaian J; Alesheikh P
    Biomed Pharmacother; 2019 Mar; 111():485-495. PubMed ID: 30594788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases.
    Zhao J; Zhu M; Kumar M; Ngo FY; Li Y; Lao L; Rong J
    CNS Neurol Disord Drug Targets; 2019; 18(2):103-114. PubMed ID: 30394219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of mangiferin and its metabolite-norathyriol, Part 2: Influence of UGT, CYP450, P-gp, and enterobacteria and the potential interaction in Rhizoma Anemarrhenae decoction with timosaponin B2 as the major contributor.
    Tian X; Xu Z; Li Z; Ma Y; Lian S; Guo X; Hu P; Gao Y; Huang C
    Biofactors; 2016 Sep; 42(5):545-555. PubMed ID: 27151461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection.
    Pallàs M; Casadesús G; Smith MA; Coto-Montes A; Pelegri C; Vilaplana J; Camins A
    Curr Neurovasc Res; 2009 Feb; 6(1):70-81. PubMed ID: 19355928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
    Forlenza OV; De-Paula VJ; Diniz BS
    ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Neuroprotective Role of Polydatin: Neuropharmacological Mechanisms, Molecular Targets, Therapeutic Potentials, and Clinical Perspective.
    Fakhri S; Gravandi MM; Abdian S; Akkol EK; Farzaei MH; Sobarzo-Sánchez E
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.